Fractional PMO
When a Fractional PMO Makes Sense for a Growing Healthcare Organization
A practical guide to recognizing when a fractional PMO may be the right operating model for a growing healthcare organization—and when a project manager or permanent PMO may fit better.
Growth can bring new care sites, acquisition integration, technology rollouts, and service-line expansion. Together, these initiatives create choices about sequence, capacity, risk, and decision authority.
A Project Management Office, or PMO, can help. In plain English, it gives several initiatives a consistent way to see work, govern decisions, and coordinate shared people and dependencies. PMI describes a PMO as a management structure that standardizes project-related governance and enables sharing of resources, methods, tools, and techniques. [1]
A fractional PMO is not a standardized credential or universal staffing formula. It is a part-time, scoped, or shared leadership arrangement for the PMO work needed now—such as portfolio governance, integration coordination, or executive decision reporting. It should fit the delivery load, not a prepackaged meeting calendar.
The operational signs are usually visible before a department is needed
A fractional PMO can make sense when the organization has more than one important initiative, but does not yet need a permanent internal PMO. These are practical observations, not diagnostic labels.
1. Leaders can list the initiatives, but cannot see the portfolio
A COO may know that a site opening, EHR module, and acquisition workstream are underway. The harder question is whether they draw on the same clinical leaders, implementation team, or technology environment. If that answer sits in separate slide decks and inboxes, a shared portfolio view may be more useful than another status meeting.
For example: protect the implementation team’s capacity for the site opening, or redirect it to an integration deadline? A PMO can make the trade-off and the sponsor’s decision visible.
2. Priorities keep changing because capacity is not explicit
Teams often hear that every initiative is important. That is not a portfolio decision. A useful cadence shows what is committed, what is conditional, what capacity is constrained, and who may change the order.
This matters when clinical, operational, finance, and technology teams are asked for the same scarce time. The goal is a fact base when a new request, delay, or risk changes the plan.
3. Sponsors spend more time assembling updates than making decisions
An executive sponsor should make choices and remove barriers—not assemble updates, chase owners, or reconstruct decisions from email. Across several initiatives, a fractional PMO can provide a decision log, escalation, clear meeting inputs, and reports that separate information from a decision request.
APM describes governance as a framework of authority and accountability, with delegated limits of authority, escalation routes, defined roles, and reporting that keeps senior stakeholders informed. [2] That is a useful standard for a lightweight operating model: enough structure to support decisions, without bureaucracy for its own sake.
4. Integration and technology dependencies have no natural owner
M&A activity and new technology expose work between functions. An integration may need operational design, workforce planning, vendor coordination, and technology readiness. No single project plan automatically resolves decision rights between those teams.
A fractional PMO can maintain an integrated view of the milestone, dependency, risk, owner, decision needed, and escalation path. It does not replace functional accountability.
5. Reporting arrives late or describes activity without the decision
Leaders need to know what changed, what is at risk, and what decision is due next. If reporting is late, incompatible between workstreams, or unable to show ownership, the missing piece may be operating discipline rather than another template.
Choose the model that matches the work
One experienced project manager may be the better fit for a single, bounded initiative with a clear sponsor, defined team, and limited cross-program dependencies. That role focuses on planning and delivering that project.
A fractional PMO fits when connected initiatives need a common portfolio view, decision cadence, shared reporting, and visible dependencies, but time-bounded leadership is sufficient. It can bridge to a long-term internal model.
A permanent internal PMO may be better when the organization has an enduring volume of projects and enough work to support dedicated leadership and staff. A fractional arrangement is not automatically cheaper. The relevant comparison is the sustained authority, capacity, and internal capability required.
What a focused engagement can include
The first deliverable should be clarity, not a heavier process. A defined engagement may establish governance scope, decision rights, sponsor roles, and a RACI—who is responsible, accountable, consulted, and informed. It may baseline the portfolio, risks, dependencies, and reporting calendar.
From there, the work can create a practical executive decision report: what is moving, what needs attention, which decision is requested, who owns the next action, and when it returns for review. The point is proportionate controls, not identical ceremony for every team.
The first 30 days are illustrative, not a guarantee or automatic transformation plan. Work might begin with sponsor and workstream interviews, a reporting review, and a map of key decisions and dependencies. It could then confirm governance forums, authority thresholds, common definitions, and an initial decision-and-risk log. Scope and access will shape what is feasible.
Five buyer questions before you start
- Who is the executive sponsor, and what decisions can that person make or escalate?
- Which initiatives, sites, integrations, or programs are in scope—and which are not?
- Where are the clinical, operational, technology, privacy, security, and vendor decision boundaries?
- What access is appropriate for confidential business information, and how will protected health information be excluded or handled under the organization’s controls?
- What decision history, templates, and ownership will transfer to internal leaders at exit?
The sponsor retains control of priorities and accountability. A fractional PMO is not an executive replacement, and accountability cannot be outsourced through a reporting cadence. Clinicians retain clinical decision-making, while technology and security specialists perform their own assessments.
Measurement should start with an observable baseline, not a promised outcome. Measures may include the number and age of unowned decisions, reporting timeliness, named owners for cross-functional dependencies, and milestone predictability against the agreed plan. They do not promise a business or clinical result.
A fictional illustration
Consider a fictional multi-site healthcare organization integrating an acquired practice while deploying a patient-access technology change. The sponsor sees two projects; operating teams see a shared implementation lead, overlapping training demands, and a timing decision. A scoped fractional PMO could establish a combined dependency view, a weekly decision forum, named owners, and a short executive report. The sponsor would choose priorities, clinicians would retain clinical judgment, and technology and security specialists would assess systems. This is not an Avara & Co. project or a promise of results.
The question is whether important work has the right visibility, authority, and follow-through. Avara & Co. is a founder-led Northern Virginia consultancy offering fractional PMO, M&A integration, strategic program management, and transformation support nationwide, including remotely, with a focus on healthcare and life sciences. Explore the fractional PMO offering or broader project and program management expertise. To discuss the support your initiative may need, request a fractional PMO consultation. Please do not include confidential business information or patient information in the form.
This article is general educational information, not medical, legal, financial, or technical advice.
Sources
